Table 5. The correlations between clinicopathological features and recurrence or metastasis after surgery in EGC patients.
| Clinicopathological features | Recurrence or Metastasis |
P | |
|---|---|---|---|
| No (n=211) | Yes (n=15) | ||
| Gender | 0.564 | ||
| Male | 147 (94.2%) | 9 (5.8%) | |
| Female | 64 (91.4%) | 6 (8.6%) | |
| Age (year) | 0.052 | ||
| <60 | 111 (96.5%) | 4 (3.5%) | |
| 360 | 100 (90.1%) | 11 (9.9%) | |
| Tumor location | 0.803 | ||
| Upper 1/3 | 29 (93.5%) | 2 (6.5%) | |
| Middle 1/3 | 58 (95.1%) | 3 (4.9%) | |
| Lower 1/3 | 124 (92.5%) | 10 (7.5%) | |
| Macroscopic type | 0.209 | ||
| I/II | 135 (91.8%) | 12 (8.2%) | |
| III/Mixed | 76 (96.2%) | 3 (3.8%) | |
| Size (cm) | 0.293 | ||
| <2.0 | 97 (91.5%) | 9 (8.5%) | |
| 32.0 | 114 (95.0%) | 6 (5.0%) | |
| Histology | 0.562 | ||
| Adenocarcinoma | 148 (92.5%) | 12 (7.5%) | |
| Other types* | 63 (95.5%) | 3 (4.5%) | |
| Differentiation | 0.845 | ||
| Differentiated | 93 (93.0%) | 7 (7.0%) | |
| Undifferentiated | 118 (93.7%) | 8 (6.3%) | |
| Ulcer | 0.886 | ||
| Absent | 180 (93.3%) | 13 (6.7%) | |
| Present | 31 (93.9%) | 2 (6.1%) | |
| Lymphovascular invasion | 0.678 | ||
| Absent | 190 (93.1%) | 14 (6.9%) | |
| Present | 21 (95.5%) | 1 (4.5%) | |
| Depth of invasion | 0.054 | ||
| Mucosa | 115 (90.6%) | 12 (9.4%) | |
| Submucosa | 96 (97.0%) | 3 (3.0%) | |
| Lymph node metastasis | |||
| No | 198 (94.7%) | 11 (5.3%) | 0.018 |
| Yes | 13 (76.5%) | 4 (23.5%) | |
| N0-1 | 208 (94.5%) | 12 (5.5%) | 0.004 |
| N2-3 | 3 (50.0%) | 3 (50.0%) | |
EGC, early gastric cancer; *, signet-ring cell carcinoma, mucinous adenocarcinoma and et al.